Isofol Medical AB (publ) publishes annual report and corporate governance report for 2022
GOTHENBURG, Sweden, April 6, 2023 – Isofol Medical AB (publ) (Nasdaq Stockholm: ISOFOL), today announced that the company’s annual report […]
Regulatory
Isofols appoints Roy Jonebrant as new acting Chief Financial Officer
Gothenburg, Sweden, March 17, 2023 – Isofol Medical AB (publ), (Nasdaq Stockholm: ISOFOL), announces today that Roy Jonebrant has been
Isofol’s board appoints Thomas Andersson as new CEO of the company
Gothenburg, Sweden, February 28, 2023 – Isofol Medical AB (publ), (Nasdaq Stockholm: ISOFOL), announces today that the board of Isofol
Bulletin from Extraordinary General Meeting in Isofol Medical AB (publ) held on February 28, 2023
Today on February 28, 2023 in Gothenburg – Isofol Medical AB (publ), (Nasdaq Stockholm: ISOFOL), held its Extraordinary General Meeting
Isofol Medical AB (publ) publishes year-end report, January – December 2022
GOTHENBURG, Sweden, February 22, 2023 – Isofol Medical AB (publ), (Nasdaq Stockholm: ISOFOL), announced today that the company’s year-end report
Bulletin from Extraordinary General Meeting in Isofol Medical AB (publ) held on February 13, 2023
Today on February 13, 2023 in Gothenburg – Isofol Medical AB (publ), (Nasdaq Stockholm: ISOFOL), held its Extraordinary General Meeting
Isofol has obtained a request to call for an extraordinary general meeting
GOTHENBURG, Sweden, January 30, 2023 – Isofol Medical AB (publ) (Nasdaq Stockholm: ISOFOL), has obtained a request to call an
Isofol invites to an informational meeting on January 30 prior to extraordinary general meeting
GOTHENBURG, Sweden, January 20, 2023 – Isofol Medical AB (publ) (Nasdaq Stockholm: ISOFOL) (“Isofol”), yesterday called shareholders to an extraordinary
Notice convening the extraordinary general meeting in Isofol Medical AB (publ) 13 February 2023
GOTHENBURG, Sweden, January 19, 2022 – Isofol Medical AB (publ), (Nasdaq Stockholm: ISOFOL), hereby invites the shareholders of Isofol Medical
Isofol Medical’s Board of Directors intends to call an extraordinary general meeting with proposals for dividends and liquidation of the company
GOTHENBURG, Sweden, January 19, 2023 – Isofol Medical AB (publ) (Nasdaq Stockholm: ISOFOL), decided today to call an extraordinary general